CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces its successful uplisting from the OTC Pink Sheets to the OTCQB Venture Market, effective today. This milestone, achieved in an unprecedented six weeks from the filing date of April 2nd, 2025, alongside the completion of SEC Rule 15c2-11 compliance, reinforces Adia's commitment to transparency, investor accessibility, and...
2025-05-16 10:11 AM EDT
Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach
Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces that it has officially filed with OTC Markets Group for uplisting to the OTCQB Venture Market. This filing follows the successful completion of an independent audit with Astra Audit and Advisory LLC on April 1, 2025, marking a significant milestone in the company's commitment to enhancing visibility, liquidity, and...
2025-05-16 8:09 AM EDT
Adia Nutrition Announces Major Share Structure Overhaul with Retirement of Approximately 15 Million Shares and Cancellation of 10 Million Share Commitment
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA), a Winter Park, Florida-based innovator in health and wellness, is excited to announce a transformative overhaul of its share structure, including the retirement of approximately 15 million shares, reducing the outstanding common stock from 95,899,861 to 80,404,696 shares, and the cancellation of a commitment agreement requiring the issuance of 10 million additional shares. These changes are now...
2025-05-05 11:02 AM EDT
Adia Nutrition Inc. Files for OTCQB Uplisting with OTC Markets, Emphasizing OTC-Handled 15c2-11 for Transparency and Investor Reach
Winter Park, Florida--(Newsfile Corp. - April 14, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces that it has officially filed with OTC Markets Group for uplisting to the OTCQB Venture Market. This filing follows the successful completion of an independent audit with Astra Audit and Advisory LLC on April 1, 2025, marking a significant milestone in the company's commitment to enhancing visibility, liquidity, and...
2025-04-14 9:00 AM EDT
Adia Nutrition Inc. Completes Independent Audit with Astra Audit and Advisory LLC., Prepares to File for OTCQB Uplisting
Winter Park, Florida--(Newsfile Corp. - April 7, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a pioneering force in advanced stem cell therapies and nutritional wellness, is proud to announce the successful completion of its independent audit, a crucial milestone that positions the company to file for uplisting to the OTCQB market. This achievement marks a significant step in Adia Nutrition's journey to enhance transparency, build investor confidence, and amplify shareholder value as it...
2025-04-07 9:00 AM EDT
Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value
Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative nutritional solutions, is pleased to announce a significant milestone for its shareholders following a recent court ruling. A judge has ordered the cancellation of over 25 million shares of Adia Nutrition stock, including more than 15 million restricted common shares and 10 million preferred shares. This landmark decision will reduce the company's outstanding shares by over 15...
2025-04-01 8:00 AM EDT
Adia Nutrition Inc. Opens First Satellite Location in Tinton Falls, NJ, Partnering with Keep Glowing Medical Spa and Dr. Michael Ellis
Winter Park, Florida--(Newsfile Corp. - March 27, 2025) - Adia Nutrition Inc. (OTC Pink: ADIA), a leader in regenerative medicine and healthcare innovation, is excited to announce the opening of its first satellite location in Tinton Falls, New Jersey. This expansion is made possible through a strategic shared space agreement with Keep Glowing Medical Spa and renowned physician Dr. Michael Ellis, blending cutting-edge stem cell therapies with an established wellness hub. Located within Keep...
2025-03-27 8:00 AM EDT
Adia Med Explores International Expansion Following Global Interest in Its Innovative Umbilical Cord Blood Stem Cell Therapies
Winter Park, Florida--(Newsfile Corp. - March 25, 2025) - Adia Nutrition (OTC Pink: ADIA), a trailblazer in advanced healthcare solutions, is excited to announce that its subsidiary, Adia Med, is actively exploring international expansion after receiving significant interest from multiple international groups. Over recent months, several organizations and healthcare entities from various countries have reached out to Adia Med, expressing enthusiasm for establishing clinics that offer its...
2025-03-25 10:15 AM EDT
Adia Med Leads Charge to Standardize Umbilical Cord Stem Cell Use Nationwide, Prepares Presentation for New Head of DHHS and FDA
Winter Park, Florida--(Newsfile Corp. - March 20, 2025) - Adia Med, a division of ADIA Nutrition Inc. (OTC Pink: ADIA), is driving a transformative effort to standardize umbilical cord stem cell use across the United States, prioritizing quality, safety, and accountability. This initiative sets rigorous best practices, mandates third-party verification, and ensures homologous applications, aiming to redefine excellence in regenerative medicine. Adia Med plans to present these pioneering...
2025-03-20 9:30 AM EDT
Adia Med to Expand Treatment Offerings with Therapeutic Plasma Exchange (TPE) Across All Future Full Clinic Locations
Winter Park, Florida--(Newsfile Corp. - March 17, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative healthcare solutions, is thrilled to announce that its subsidiary, Adia Med, will ensure that all future full clinic locations across the United States will offer Therapeutic Plasma Exchange (TPE), with its current location already offering this advanced treatment as of today. These full clinics, which will also perform Hematopoietic Stem Cell Transplantation (HSCT) for various...
2025-03-17 8:30 AM EDT
Adia Nutrition Hunts for Top Sales Talent to Power Adia Med and Adia Labs Expansion
Winter Park, Florida--(Newsfile Corp. - March 13, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in health, wellness, and regenerative medicine, is thrilled to announce it is recruiting dynamic sales representatives for its subsidiaries, Adia Med and Adia Labs, with job postings now live on Indeed. This bold initiative, a key part of ADIA Nutrition's roadmap for success and profitability, will propel the company's mission to deliver cutting-edge stem cell therapies and...
2025-03-13 9:00 AM EDT
ADIA Nutrition Strengthens Team to Optimize Operations and Advance Regenerative Medicine Excellence
Winter Park, Florida--(Newsfile Corp. - March 11, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, is proud to announce the expansion of its workforce with two strategic hires designed to enhance operations and elevate standards in stem cell therapy. These additions reflect ADIA Nutrition's dedication to scaling its Adia Med division with efficiency and innovation as it grows nationwide. ADIA Nutrition has welcomed a skilled intake...
2025-03-11 10:15 AM EDT
Adia Nutrition Moves to Secure Brand Identity with Trademark Filings
Winter Park, Florida--(Newsfile Corp. - March 5, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a frontrunner in health and wellness innovation, is fortifying its brand legacy by filing trademark applications with the U.S. Patent and Trademark Office (USPTO) for its new product, "Adia Vita," and its bold slogan, "The Platinum Standard in Stem Cell Therapy," both now pending approval. The purpose of these trademarks is to protect ADIA Nutrition's brand from copycats who use inferior products,...
2025-03-05 8:00 AM EST
Adia Labs Secures FDA Registration for Adia Vita, Expands Regenerative Medicine Nationwide
Winter Park, Florida--(Newsfile Corp. - March 3, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new subsidiary, Adia Labs LLC: the FDA has accepted the registration of Adia Vita. This acceptance reflects Adia Labs' notification to the FDA that it will be storing and distributing its premier stem cell product, Adia Vita, to doctors and clinics nationwide, broadening access to cutting-edge regenerative medicine...
2025-03-03 8:30 AM EST
ADIA Nutrition Inc. Ignites 2025 with February Breakthroughs, Riding Adia Med's Profitable January Triumph
Winter Park, Florida--(Newsfile Corp. - February 28, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a pioneer in healthcare innovation and regenerative medicine, concludes an extraordinary February with groundbreaking advancements in stem cell therapies, strategic partnerships, and a pivotal corporate milestone. These achievements, layered atop January's financial triumph at the Adia Med Winter Park Clinic, underscore ADIA Nutrition's unstoppable momentum toward revolutionizing healthcare,...
2025-02-28 10:30 AM EST
Adia Nutrition Announces Successful Removal of Shell Risk Designation by OTC Markets, Advancing Toward OTCQB Uplisting
Winter Park, Florida--(Newsfile Corp. - February 26, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in innovative nutritional products and regenerative medical treatments, is excited to announce that it has successfully removed its shell risk designation from OTC Markets, a pivotal achievement on its accelerated journey to uplist from the OTC Pink Sheets to the OTCQB Venture Market. The company extends its heartfelt gratitude to OTC Markets for their collaboration and swift action in...
2025-02-26 9:30 AM EST
ADIA Nutrition Inc. Embarks on Nationwide Expansion of Adia Med Satellite Locations
Winter Park, Florida--(Newsfile Corp. - February 24, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in healthcare innovation and regenerative medicine, proudly announces its strategic expansion plan for Adia Med satellite locations across the United States. This initiative aims to make Adia Med's innovative treatments more accessible by partnering with premier Medical Spas dedicated to anti-aging, wellness, and body repair. ADIA Nutrition Inc. Embarks on Na
2025-02-24 10:15 AM EST
ADIA Nutrition Proudly Launches Adia Labs LLC and Begins Sales of Branded Stem Cell Products
Winter Park, Florida--(Newsfile Corp. - February 20, 2025) - ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare and supplementation, proudly announces the launch of Adia Labs LLC, a new division dedicated to advancing regenerative medicine. This initiative underscores ADIA Nutrition's commitment to providing high-quality products for the research and medical community. To view an enhanced version of this graphic, please visit:
2025-02-20 10:00 AM EST
Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products
Winter Park, Florida--(Newsfile Corp. - February 18, 2025) - Adia (OTC Pink: ADIA) Med is proud to announce a strategic partnership with an FDA-approved laboratory in the field of regenerative medicine. This collaboration marks a new era in the availability of top-tier, third-party verified, and minimally manipulated umbilical cord stem cell and exosome products. Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord
2025-02-18 8:00 AM EST
Adia Med Advances Towards AHCA Registration to Expand Insurance Coverage for Stem Cell Therapies
Winter Park, Florida--(Newsfile Corp. - February 13, 2025) - Adia Med, the medical division of Adia Nutrition Inc. (OTC Pink: ADIA), proudly announces its ongoing registration with the State of Florida's Agency for Health Care Administration (AHCA). This crucial initiative is designed to secure approval for accepting private insurance for Adia Med's pioneering stem cell therapies including Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatment and injectable stem cells, thereby...
2025-02-13 8:00 AM EST